Sankyo Drug Patent Portfolio
Sankyo owns 1 orange book drug protected by 4 US patents Given below is the list of Sankyo's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5859037 | Sulfonylurea-glitazone combinations for diabetes | 13 Nov, 2017 | Expired |
| US6011049 | Combinations for diabetes | 13 Nov, 2017 | Expired |
| US5602133 | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus | 15 Sep, 2013 | Expired |
| US6046202 | Use of thiazolidinedione derivatives in the treatment of insulin resistance | 15 Sep, 2013 | Expired |
Sankyo's Family Patents
Clinical Trials
Recent Clinical Trials by Sankyo:
Sankyo Drug List
Given below is the complete list of Sankyo's drugs and the patents protecting them.
1. Prelay
Prelay is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5859037 | Sulfonylurea-glitazone combinations for diabetes |
13 Nov, 2017
(8 years ago)
| Expired |
| US6011049 | Combinations for diabetes |
13 Nov, 2017
(8 years ago)
| Expired |
| US5602133 | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
15 Sep, 2013
(13 years ago)
| Expired |
| US6046202 | Use of thiazolidinedione derivatives in the treatment of insulin resistance |
15 Sep, 2013
(13 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Prelay's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List